Waters (WAT) Competitors $374.55 +0.83 (+0.22%) (As of 11:21 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends WAT vs. A, MTD, ILMN, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Waters stock or one of its competitors? The main competitors of Waters include Agilent Technologies (A), Mettler-Toledo International (MTD), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Waters vs. Agilent Technologies Mettler-Toledo International Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Waters (NYSE:WAT) are both large-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings. Is A or WAT more profitable? Waters has a net margin of 21.43% compared to Agilent Technologies' net margin of 19.80%. Waters' return on equity of 49.93% beat Agilent Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies19.80% 25.43% 13.79% Waters 21.43%49.93%14.96% Do analysts rate A or WAT? Agilent Technologies presently has a consensus target price of $143.62, indicating a potential upside of 5.84%. Waters has a consensus target price of $375.85, indicating a potential upside of 0.74%. Given Agilent Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Agilent Technologies is more favorable than Waters.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 1 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.43Waters 1 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.29 Do institutionals & insiders have more ownership in A or WAT? 87.4% of Agilent Technologies shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 0.3% of Agilent Technologies shares are held by insiders. Comparatively, 0.8% of Waters shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, A or WAT? Agilent Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Waters has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Does the MarketBeat Community prefer A or WAT? Agilent Technologies received 428 more outperform votes than Waters when rated by MarketBeat users. Likewise, 71.06% of users gave Agilent Technologies an outperform vote while only 53.45% of users gave Waters an outperform vote. CompanyUnderperformOutperformAgilent TechnologiesOutperform Votes86271.06% Underperform Votes35128.94% WatersOutperform Votes43453.45% Underperform Votes37846.55% Which has better valuation & earnings, A or WAT? Agilent Technologies has higher revenue and earnings than Waters. Agilent Technologies is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.51B5.99$1.29B$4.4230.70Waters$2.91B7.63$642.23M$10.4835.60 Does the media favor A or WAT? In the previous week, Agilent Technologies and Agilent Technologies both had 29 articles in the media. Agilent Technologies' average media sentiment score of 0.65 beat Waters' score of 0.51 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 10 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Waters 10 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAgilent Technologies and Waters tied by winning 9 of the 18 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get Waters News Delivered to You Automatically Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WAT vs. The Competition Export to ExcelMetricWatersAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$22.15B$5.57B$5.15B$19.68BDividend YieldN/A0.42%4.81%3.51%P/E Ratio35.6025.68135.4243.79Price / Sales7.634.391,184.6217.84Price / Cash25.9344.4440.4221.73Price / Book19.182.324.895.48Net Income$642.23M$2.05M$118.71M$987.88M7 Day Performance-3.16%-0.51%15.74%-2.00%1 Month Performance4.96%3.82%15.70%1.00%1 Year Performance15.75%-23.25%34.85%16.82% Waters Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WATWaters3.8243 of 5 stars$374.55+0.2%$375.85+0.3%+16.7%$22.24B$2.91B35.747,900AAgilent Technologies4.7561 of 5 stars$137.87-0.8%$143.62+4.2%-0.2%$39.61B$6.51B31.4518,100Short Interest ↓Analyst RevisionMTDMettler-Toledo International4.1379 of 5 stars$1,267.86-0.7%$1,351.25+6.6%+4.6%$26.76B$3.76B34.4317,300Positive NewsILMNIllumina4.4343 of 5 stars$143.58-0.2%$165.95+15.6%+12.6%$22.77B$4.39B-14.449,300Short Interest ↑TECHBio-Techne4.3175 of 5 stars$76.44+1.0%$82.00+7.3%-0.9%$12.15B$1.17B81.073,100Short Interest ↑Positive NewsCRLCharles River Laboratories International4.6361 of 5 stars$191.47+0.5%$214.00+11.8%-17.9%$9.79B$4.06B23.8421,800Positive NewsBIOBio-Rad Laboratories4.4475 of 5 stars$340.35+1.2%$394.20+15.8%+10.2%$9.53B$2.58B-12.308,030Short Interest ↓Positive NewsBRKRBruker4.9938 of 5 stars$57.37-0.6%$74.70+30.2%-21.2%$8.70B$2.96B27.759,707Short Interest ↑PACBPacific Biosciences of California1.5354 of 5 stars$2.03+3.6%$2.95+45.5%-79.1%$555.94M$200.52M-1.46730Gap UpHBIOHarvard Bioscience1.117 of 5 stars$2.11-2.3%N/A-55.7%$92.03M$97.73M-6.55490TMOThermo Fisher Scientific4.8618 of 5 stars$533.21+1.2%$652.30+22.3%+2.1%$203.95B$42.86B33.03122,000Analyst RevisionPositive News Related Companies and Tools Related Companies A Competitors MTD Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors HBIO Competitors TMO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:WAT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waters Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Waters With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
